Summary
- Current Price
- As of today, MDLN price is $41.36, down -2.01% on
- Current Price All-Time High
- MDLN price is currently -18.70% below its historical high of $50.88 set on
- Market Cap
- MDLN current market cap is $34B, with unknown 1-year change
- PE Ratio
- MDLN current PE ratio is 28.61
- Revenue
- MDLN current annual revenue is $28.43B, up +11.47% year-over-year
- Next Earnings
- The next earnings release for MDLN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Medline Inc. |
| Ticker | NASDAQ: MDLN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | medline.com |
| Employees | 43,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $41.36 | |
| Price, 1D Change | -2.01% | |
| Market Cap | $34B | |
| - | ||
| PE Ratio | 28.61 | |
| Beta | 0.53 | |
| Revenue | $28B | |
| Revenue, 1Y Change | +11.47% | |
| EPS | $1.43 | |
| EPS, 1Y Change | -4.87% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.43 | |
| EPS Estimate | N/A | $1.47 |
| EPS Est. Change | N/A | +3.11% |
| Revenue | $28.43B | |
| Revenue Estimate | N/A | $30.91B |
| Revenue Est. Change | N/A | +8.70% |
| Current Price | $41.36 | |
| Price Target | - | $55.00 |
| Price Tgt. Change | - | +32.98% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.22 | $1.43 | +17.43% | |
| $1.47 | N/A | +3.11% | |
| $1.66 | N/A | +16.19% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $28.16B | $28.43B | +0.98% | |
| $30.91B | N/A | +8.70% | |
| $33.28B | N/A | +17.06% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | - | |
| Price, 3Y | - | |
| Market Cap, 1Y | - | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +11.47% | |
| Revenue, 3Y | +32.56% | |
| EPS, 1Y | -4.87% | |
| EPS, 3Y | +4,660.06% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $41.36 | |
| SMA 200 | $43.89 | |
| SMA 200 vs Price | +6.12% | |
| SMA 50 | $44.71 | |
| SMA 50 vs Price | +8.11% | |
| Beta | 0.53 | |
| ATR | $1.52 | |
| 14-Day RSI | 39.23 | |
| 10-Day Volatility | 26.08% | |
| 1-Year Volatility | 40.45% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $28.43B | |
| EPS | $1.43 | |
| Gross Profit | $0.00 | |
| Gross Margin | 23.97% | |
| Operating Profit | $2.21B | |
| Operating Margin | 7.78% | |
| Net Income | $1.16B | |
| Net Margin | 4.07% | |
| EBITDA | $3.22B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.21 | |
| 4.29 | ||
| 2.37 | ||
| - | ||
| - | ||
| 2.26 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 28.61 | |
| 1.21 | ||
| 3.21 | ||
| 14.08 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $10.74B | |
| $1.94B | ||
| $38.48B | ||
| $10.68B | ||
| $19.20B | ||
| $2.49B | ||
| Total Debt | $13.01B | |
| $143.00M | ||
| $961.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $27.27B | ||
| $4.60B | ||
| $21.62B | ||
| $0.00 | ||
| $1.01B | ||
| $0.00 | ||
| $91.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $1.74B | ||
| -$474.00M | ||
| $399.00M | ||
| Capex | $480.00M | |
| $1.74B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Tigress Financial | → | |
| BTIG | → | |
| Morgan Stanley | → | |
| Wells Fargo | → | |
| UBS | → | |
| RBC Capital | → | |
| Evercore ISI Group | → | |
| Citigroup | → | |
| BMO Capital | → |
Analyst sentiment
Institutional ownership
Screeners with MDLN
FAQ
What is the ticker symbol for Medline Inc.?
The ticker symbol for Medline Inc. is NASDAQ:MDLN
Does Medline Inc. pay dividends?
No, Medline Inc. does not pay dividends
What sector is Medline Inc. in?
Medline Inc. is in the Healthcare sector
What industry is Medline Inc. in?
Medline Inc. is in the Medical Instruments & Supplies industry
What country is Medline Inc. based in?
Medline Inc. is headquartered in United States
When did Medline Inc. go public?
Medline Inc. initial public offering (IPO) was on December 17, 2025
Is Medline Inc. in the S&P 500?
No, Medline Inc. is not included in the S&P 500 index
Is Medline Inc. in the NASDAQ 100?
No, Medline Inc. is not included in the NASDAQ 100 index
Is Medline Inc. in the Dow Jones?
No, Medline Inc. is not included in the Dow Jones index
When was Medline Inc. last earnings report?
Medline Inc.'s most recent earnings report was on February 25, 2026
When does Medline Inc. report earnings?
The next expected earnings date for Medline Inc. is May 29, 2026
Data Sources & References
- MDLN Official Website www.medline.com
- MDLN Profile on Yahoo Finance finance.yahoo.com/quote/MDLN
- MDLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdln